Madrigal Pharmaceuticals, Inc. Stock Forecast

Sell candidate since Jan 13, 2025 Loss -3.31%

The Madrigal Pharmaceuticals, Inc. stock price gained 7.64% on the last trading day (Friday, 17th Jan 2025), rising from $272.79 to $293.64. During the last trading day the stock fluctuated 11.43% from a day low at $270.51 to a day high of $301.44. The price has risen in 7 of the last 10 days but is still down by -6.42% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 487 thousand more shares were traded than the day before. In total, 853 thousand shares were bought and sold for approximately $250.49 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 16.85% during the next 3 months and, with a 90% probability hold a price between $300.02 and $466.44 at the end of this 3-month period.

Investment opportunities can be found at any hour. So, react immediately to market-moving news and capture more market opportunities when convenient for you. You can trade over 10,000 US Stocks and ETFs, US Equity Index options, US Treasuries – and more - around the clock. Interactive Brokers’ dual market centers ensure reliable and dependable overnight trading on your timetable. (Member SIPC)

MDGL Signals & Forecast

Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Madrigal Pharmaceuticals, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $298.71 and $310.96. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, November 07, 2024, and so far it has fallen -17.25%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Madrigal Pharmaceuticals, Inc. stock

Madrigal Pharmaceuticals, Inc. finds support from accumulated volume at $288.58 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $30.93 between high and low, or 11.43%. For the last week, the stock has had daily average volatility of 10.23%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (MDGL) For The Upcoming Trading Day Of Tuesday 21st

For the upcoming trading day on Tuesday, 21st we expect Madrigal Pharmaceuticals, Inc. to open at $288.53, and during the day (based on 14 day Average True Range), to move between $276.24 and $311.04, which gives a possible trading interval of +/-$17.40 (+/-5.92%) up or down from last closing price. If Madrigal Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 11.85% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $288.58 (1.72%) than the resistance at $303.71 (3.43%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Madrigal Pharmaceuticals, Inc. stock A Buy?

The Madrigal Pharmaceuticals, Inc. stock holds several negative signals and despite the positive trend, we believe Madrigal Pharmaceuticals, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -2.235 Sell Candidate Unchanged

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

Predicted Fair Opening Price

Predicted fair opening price on January 21, 2025 - $288.53 ( 1.74%).